Olivier Loeillot

Insider Reports History

Location
Waltham, MA
Signature
/s/ Jennifer Carmichael (Attorney in Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Loeillot:

Company Role Class Num Shares Value Price $ Report Date Ownership
REPLIGEN CORP Chief Executive Officer, Director Common Stock 35,898 $6,102,660 $170.00 25 Nov 2025 Direct
REPLIGEN CORP Chief Executive Officer, Director Stock Option (Right to Buy) 13,627 03 Mar 2025 Direct

Insider Reports Filed by Olivier Loeillot

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGEN REPLIGEN CORP 25 Nov 2025 1 -$1,196,970 4 Chief Executive Officer, Director 26 Nov 2025, 16:30
RGEN REPLIGEN CORP 02 Oct 2025 1 -$181,247 4 Chief Executive Officer, Director 06 Oct 2025, 10:59
RGEN REPLIGEN CORP 03 Sep 2025 1 -$291,147 4 Chief Executive Officer, Director 04 Sep 2025, 10:55
RGEN REPLIGEN CORP 03 Mar 2025 2 $0 4 Chief Executive Officer, Director 04 Mar 2025, 13:18
RGEN REPLIGEN CORP 27 Feb 2025 1 -$53,693 4 Chief Executive Officer, Director 28 Feb 2025, 16:30
RGEN REPLIGEN CORP 20 Nov 2024 1 -$106,256 4 Chief Executive Officer, Director 21 Nov 2024, 13:32
RGEN REPLIGEN CORP 03 Sep 2024 2 $0 4 Chief Executive Officer, Director 04 Sep 2024, 20:41
RGEN REPLIGEN CORP 27 Feb 2024 2 $0 4 President and CCO 29 Feb 2024, 19:07
RGEN REPLIGEN CORP 02 Oct 2023 2 $0 4 President and CCO 03 Oct 2023, 20:44
RGEN REPLIGEN CORP 02 Oct 2023 0 $0 3 President and CCO 03 Oct 2023, 20:03